Covista Inc. (CVSA)

Revenue Breakdown

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013
Chamberlain Revenue	744.26M	725.77M	633.52M
Chamberlain Revenue Growth	2.55%	14.56%	10.94%
Walden Revenue	776.29M	693.43M	595.33M
Walden Revenue Growth	11.95%	16.48%	11.54%
Medical and Veterinary Revenue	389.26M	369.09M	355.80M
Medical and Veterinary Revenue Growth	5.46%	3.74%	2.81%
Revenue (Other)	1,000.00	-	-2.00K
Revenue (Total)	1.91B	1.79B	1.58B
Revenue (Total) Growth	6.79%	12.85%	9.22%

Revenue by Geography

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013
Domestic Operations Revenue	1.52B	1.42B	1.23B
Domestic Operations Revenue Growth	7.14%	15.49%	11.23%
Barbados, St. Kitts, and St. Maarten Revenue	389.26M	369.09M	355.80M
Barbados, St. Kitts, and St. Maarten Revenue Growth	5.46%	3.74%	2.81%
Revenue (Other)	3.00K	4.00K	2.00K
Revenue (Total)	1.91B	1.79B	1.58B
Revenue (Total) Growth	6.79%	12.85%	9.22%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013
Tuition and Fees Revenue	1.90B	1.78B	1.57B
Tuition and Fees Revenue Growth	6.92%	13.19%	9.18%
Other Segment Revenue	8.29M	9.87M	13.41M
Other Segment Revenue Growth	-16.01%	-26.37%	14.18%
Revenue (Total)	1.91B	1.79B	1.58B
Revenue (Total) Growth	6.79%	12.85%	9.22%

Adjusted EBITDA

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013
Chamberlain Adjusted EBITDA	183.80M	191.40M	166.19M
Chamberlain Adjusted EBITDA Growth	-3.97%	15.17%	5.53%
Walden Adjusted EBITDA	250.95M	206.48M	146.79M
Walden Adjusted EBITDA Growth	21.54%	40.66%	18.65%
Medical and Veterinary Adjusted EBITDA	100.32M	88.80M	88.89M
Medical and Veterinary Adjusted EBITDA Growth	12.97%	-0.10%	7.34%
Home Office Adjusted EBITDA	-30.06M	-26.97M	-24.34M
Operating Income (Other)	-140.16M	-118.16M	-160.48M
Operating Income (Total)	364.86M	341.54M	217.05M
Operating Income (Total) Growth	6.83%	57.35%	29.07%

Adjusted EBIT

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013
Chamberlain Adjusted Operating Income	143.07M	153.37M	137.80M
Chamberlain Adjusted Operating Income Growth	-6.72%	11.30%	1.70%
Walden Operating Adjusted Operating Income	223.70M	183.58M	130.55M
Walden Operating Adjusted Operating Income Growth	21.85%	40.62%	18.29%
Medical and Veterinary Adjusted Operating Income	78.39M	69.25M	71.51M
Medical and Veterinary Adjusted Operating Income Growth	13.20%	-3.15%	6.19%
Home Office Adjusted Operating Income	-39.04M	-36.03M	-31.08M
Operating Income (Other)	-41.26M	-28.63M	-91.72M
Operating Income (Total)	364.86M	341.54M	217.05M
Operating Income (Total) Growth	6.83%	57.35%	29.07%

EBIT

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013
Chamberlain Operating Income	141.04M	151.46M	137.80M
Chamberlain Operating Income Growth	-6.88%	9.91%	2.31%
Walden Operating Income	212.02M	177.91M	77.18M
Walden Operating Income Growth	19.17%	130.52%	115.10%
Medical and Veterinary Operating Income	77.32M	68.80M	71.07M
Medical and Veterinary Operating Income Growth	12.38%	-3.19%	19.14%
Home Office Operating Income	-65.52M	-56.62M	-68.99M
Operating Income (Total)	364.86M	341.54M	217.05M
Operating Income (Total) Growth	6.83%	57.35%	29.07%

Key Performance Indicators

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013
Chamberlain - Total Student Enrollment	40.77K	38.89K	36.75K
Chamberlain - Total Student Enrollment Growth	4.82%	5.83%	10.41%
Walden - Total Student Enrollment	54.47K	48.12K	41.85K
Walden - Total Student Enrollment Growth	13.21%	14.99%	11.34%
Medical and Veterinary - Total Student Enrollment	5.34K	4.77K	4.73K
Medical and Veterinary - Total Student Enrollment Growth	11.96%	0.99%	-2.94%
Total Student Enrollment	100.59K	91.78K	83.32K
Total Student Enrollment Growth	9.59%	10.15%	10.02%

Data Source: Fiscal.ai Last updated: May 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error